Press release
Parkinsons Disease Therapeutics Market to Grow with Incredible Possibilities, and is Projected to Reach USD 6.31 billion by 2031 | UCB S.A., AbbVie Inc., Acadia Pharmaceuticals Inc., Abbott Laboratories
The latest report on Parkinsons Disease Therapeutics Market offers valuable insights into emerging trends and pivotal developments within the market. It highlights significant growth opportunities that market participants can leverage, alongside strategic recommendations for capitalizing on these trends. This report serves as an indispensable tool for stakeholders seeking to deepen their understanding of the market landscape and identify actionable pathways for growth. By utilizing this in-depth analysis, stakeholders will gain the insights necessary to effectively adapt to shifting market conditions and strengthen their competitive position.The Global Parkinson's Disease Therapeutics Market reached US$ 4.02 billion in 2023 and is expected to reach US$ 6.31 billion by 2031, growing at a CAGR of 5.9% during the forecast period 2024-2031.
Download a Free sample PDF (Use Corporate email ID to Get Higher Priority) at: - https://datamintelligence.com/download-sample/parkinsons-disease-therapeutics-market
Parkinson's Disease (PD) therapeutics encompass a variety of treatments aimed at managing the symptoms and progression of Parkinson's Disease, a neurodegenerative disorder primarily affecting movement and coordination.
Key Developments:
❁ On February 1, 2021, Eisai Co., Ltd. released that Eisai Korea Inc., Eisai's subsidiary in South Korea, launched the Parkinson's disease treatment Equfina (safinamide mesilate, "safinamide"). Safinamide is a selective monoamine oxidase B (MAO-B) inhibitor, which reduces the degradation of excreted dopamine, helping to maintain the density of dopamine in the brain. Additionally, safinamide blocks sodium ion channels and inhibits glutamate release, and as such has potential as a new Parkinson's disease treatment that possesses both dopaminergic and non-dopaminergic mechanisms.
List of the Key Players in the Parkinsons Disease Therapeutics Market:
UCB S.A., AbbVie Inc., Acadia Pharmaceuticals Inc., Abbott Laboratories, Kyowa Kirin Co., Ltd., Teva Pharmaceutical Industries Ltd., Mylan N.V., Eisai Co., Ltd., Supernus Pharmaceuticals, Inc. and Acorda Therapeutics, Inc. among others.
Research Process:
Both primary and secondary data sources have been used in the global Parkinsons Disease Therapeutics Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
Segment Covered in the Parkinsons Disease Therapeutics Market:
By Disease Type (Familial Parkinson's Disease, Idiopathic Parkinson's Disease, Induced Parkinsonism)
By Treatment (Medications, Deep Brain Stimulation Systems, Others)
By Route of Administration (Oral, Transdermal, Intravenous, Others)
By Sales Channel (Distribution Channel, End-User)
Regions Covered:
The global Parkinsons Disease Therapeutics Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa.
Get this Premium Report: https://www.datamintelligence.com/buy-now-page?report=parkinsons-disease-therapeutics-market
Regional Analysis:
The global Parkinsons Disease Therapeutics Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. The report offers detailed insight into new product launches, new technology evolutions, innovative services, and ongoing R&D. The report discusses a qualitative and quantitative market analysis, including PEST analysis, SWOT analysis, and Porter's five force analysis. The Parkinsons Disease Therapeutics Market report also provides fundamental details such as raw material sources, distribution networks, methodologies, production capacities, industry supply chain, and product specifications.
**The full version of the report includes an in-depth analysis of emerging players and startups, which will provide valuable insights into the evolving market landscape and key strategies being adopted**
Points Covered:
⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Parkinsons Disease Therapeutics market segments, study objectives, and years considered.
⏩ Market Landscape: The competition in the Global Parkinsons Disease Therapeutics Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.
⏩ Companies Profiles: The global Parkinsons Disease Therapeutics market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.
⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.
⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Parkinsons Disease Therapeutics Market.
⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.
⏩ Research Findings: This section of the report showcases the findings and analysis of the report.
⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.
Get Customization in the report as per your requirements: https://datamintelligence.com/customize/parkinsons-disease-therapeutics-market
Frequently Asked Questions
● What is the expected growth rate of the global market for the forecast period?
● What are the key driving factors that are responsible to shape the fate of the Parkinsons Disease Therapeutics market during the forecast period?
● What will be the overall size of the market during the analysis period?
● What are the prominent market trends which influence the development of the Parkinsons Disease Therapeutics market across various regions?
● Who are the key market players and the market strategies that have helped them to secure the leading position in the global market?
● What are the challenges and threats that are likely to act as a barrier to the growth of the Parkinsons Disease Therapeutics market?
● What are the major opportunities that the companies can get to attain success in the world?
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Parkinsons Disease Therapeutics Market to Grow with Incredible Possibilities, and is Projected to Reach USD 6.31 billion by 2031 | UCB S.A., AbbVie Inc., Acadia Pharmaceuticals Inc., Abbott Laboratories here
News-ID: 3693678 • Views: …
More Releases from DataM intelligence 4 Market Research LLP

United States Microflute Market 2025 | Growth Drivers, Key Players & Investment …
Microflute Market is expected to grow at a Higher CAGR during the forecast period 2024-2031.
Microflute Market report, published by DataM Intelligence has released its latest in-depth analysis on the global Microflute Market, delivering a detailed overview of regional growth patterns, market segmentation, CAGR, and financial performance among leading industry players. The report offers readers a clear snapshot of the current market value and volume, alongside an exploration of emerging…

Europe Aroma Ingredients Market Analysis, Size | Share, Trends & Growth Forecast …
"The Europe Aroma Ingredients Market is expected to grow at a High CAGR throughout the forecast period(2024-2031)." As per DataM intelligence research report
Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/europe-aroma-ingredients-market?sp
Europe: Aroma Ingredients-Recent Developments & Innovations
✅ July 2025 - The International Fragrance Association (IFRA) published its updated Transparency List, detailing thousands of fragrance and functional ingredients in use including over a thousand natural complex substances enhancing industry…

Europe Surface Disinfectant Market Size, Share | Trends & Growth Forecast 2025
"The Europe Surface Disinfectant Market is expected to grow at a CAGR of 7.4% during the forecast period 2023-2030." As per DataM intelligence research report
Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/europe-surface-disinfectant-market?sp
Europe: Surface Disinfectant Recent Developments
✅ July 2025 - The European regulatory framework under the Biocidal Products Regulation introduced stricter approval requirements, driving manufacturers to invest in new biodegradable and plant-based disinfectants that deliver both high…

Europe, North America, and Asia-Pacific Automotive Liquid Condenser Market | Siz …
"The Europe, North America and Asia-Pacific Automotive Liquid Condenser Market is expected to grow at a high CAGR during the forecasting period (2023-2030)." As per DataM intelligence research report
Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/europe-north-america-and-asia-pacific-automotive-liquid-condenser-market?sp
Europe: Automotive Liquid Condenser Innovations
✅ In mid-2025, German research institutions launched a collaborative project with Mahle to develop ultra-efficient, lightweight liquid condenser systems optimized for EV platforms. These prototypes feature integrated…
More Releases for Parkinson
Key Trends Reshaping the Wolff Parkinson White Syndrome Market: Technological Ad …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
Wolff Parkinson White Syndrome Market Size Growth Forecast: What to Expect by 2025?
The market for Wolff Parkinson White syndrome has registered consistent growth over the recent past. The expectation is that it will expand from $1.17 billion in 2024 to $1.22 billion in 2025, reflecting a compound annual growth rate (CAGR) of 4.5%.…
Evolving Market Trends In The Anti-Parkinson Drugs Industry: Innovative Advancem …
The Anti-Parkinson Drugs Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Anti-Parkinson Drugs Market Size During the Forecast Period?
The anti-parkinson drugs market has seen significant growth in recent years, projected to increase from $10.37 billion in 2024 to $11.08 billion in…
What's Driving the Anti-Parkinson Drugs Market 2025-2034: Increasing Geriatric P …
What Are the Projections for the Size and Growth Rate of the Anti-Parkinson Drugs Market?
In recent times, the market size for anti-Parkinson drugs has experienced robust growth. The market, which is projected to rise from $10.37 billion in 2024 to $11.08 billion in 2025, boasts a compound annual growth rate (CAGR) of 6.9%. The past growth trend can be credited to an aging demographic, a surge in disease incidence, enhanced…
What's Driving the Anti-Parkinson Drugs Market 2025-2034: Increasing Geriatric P …
What Are the Projections for the Size and Growth Rate of the Anti-Parkinson Drugs Market?
In recent times, the market size for anti-Parkinson drugs has experienced robust growth. The market, which is projected to rise from $10.37 billion in 2024 to $11.08 billion in 2025, boasts a compound annual growth rate (CAGR) of 6.9%. The past growth trend can be credited to an aging demographic, a surge in disease incidence, enhanced…
Wolff Parkinson White Syndrome Treatment Market Overview 2024-2033
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.
Wolff Parkinson White Syndrome Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.
The Market Size Is Expected To Reach $1.43 billion…
Anti-Parkinson Drugs Market Overview
Exhibiting robust growth, the anti-parkinson drugs market is set to escalate from $9.73 billion in 2023 to $10.43 billion in 2024, with a notable Compound Annual Growth Rate (CAGR) of 7.2%. The trajectory continues on an upward trend, with an anticipated market size of $13.36 billion by 2028, sustaining a robust CAGR of 6.4%.
Increasing Geriatric Population Driving Demand:
The burgeoning geriatric population, coupled with a surge in Parkinson's disease cases,…